|
07 Jun 2007 |
All patients are enrolled in Curalogic’s clinical EU phase III trial with the ragweed product
|
|
06 Jun 2007 |
Encouraging clinical activity of GSK's novel cancer immunotherapeutic confirmed in phase II study in patients with most common form of lung cancer
|
|
06 Jun 2007 |
IDM Pharma Presents Preliminary Results from Phase II UVIDEM(R) Melanoma Vaccine Clinical Trial
|
|
06 Jun 2007 |
Coley Pharmaceutical Group's Vaccine Adjuvant, VaxImmune, to Enter Phase III Clinical Testing as Part of GlaxoSmithKline's Novel Cancer Immunotherapeutic in Non-Small Cell Lung Cancer
|
|
05 Jun 2007 |
IDM Pharma Presents Interim Phase II Data From EP-2101 Lung Cancer Vaccine Clinical Trial
|
|
05 Jun 2007 |
Introgen Announces Positive Phase 2 Clinical Trial Results with INGN 225 Immunotherapy in Patients with Small Cell Lung Cancer
|
|
02 Jun 2007 |
Transgene to Receive First Milestone Payment of EUR 10 Million From Roche Following FDA and EMEA Review of TG 4001 (R3484) Phase III Studies Plan
|
|
02 Jun 2007 |
Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
|
|
01 Jun 2007 |
Vaxfectin(TM)-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
|
|
01 Jun 2007 |
Dendreon Announces FDA Confirms Data Required for Provenge(R) Licensure
|
|
26 May 2007 |
Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
|
|
26 May 2007 |
MedImmune Receives Correspondence From FDA Regarding FluMist(R)
|
|
25 May 2007 |
Cytos Biotechnology reports results from a phase I/IIa study
|
|
25 May 2007 |
Celldex Therapeutics Initiates a Definitive Phase 2/3 Clinical Trial of CDX- 110 in Patients with Glioblastoma Multiforme
|
|
24 May 2007 |
VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
|
|
23 May 2007 |
Enzo Biochem Individualized Oral Immune Regulation Therapy
|
|
22 May 2007 |
Genitope Corporation Initiates Clinical Trial to Evaluate Use of MyVax(R) Personalized Immunotherapy Following Treatment With Rituximab and Chemotherapy for Follicular Non-Hodgkin's Lymphoma
|
|
19 May 2007 |
AVANT's Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
|
|
18 May 2007 |
Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of Tovaxin(TM) for Treatment of Multiple Sclerosis
|
|
18 May 2007 |
Data Published in The Lancet Show GARDASIL(R) was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
|
|
18 May 2007 |
Staphylococcus aureus vaccine development on track - safe and immunogenic in Phase I clinical trials
|
|
18 May 2007 |
Acambis' ACAM2000 receives positive recommendations from Advisory Committee
|
|
17 May 2007 |
Next Generation Nasal Spray Against Influenza: Clinical Phase I Study Started With FLUVACCdelNS1
|
|
16 May 2007 |
Cytos Biotechnology reports positive results from placebo controlled phase IIa study in patients suffering from house dust mite allergy
|
|
16 May 2007 |
In a phase II clinical trial, Curalogic has shown that its grass product is well tolerated without up-dosing
|
